Stock vs Stock Comparison

Merck & Co., Inc. vs Agilent Technologies, Inc.

A wins the Tale of the Tape 5–4.

MRK$115.65
A$137.40

🏆 Tale of the Tape

45
MRKA
28.1%Profitability (Net Margin)18.8%
33.4xValuation (P/E)27.3x
16.3%Efficiency (ROIC)11.8%
4/9Health (Piotroski F)5/9
4.0Safety (Altman Z)4.6
1.3%Growth (Rev YoY)6.7%
1.43Risk (Sharpe 1Y)0.32
1.60xBalance Sheet (D/E)0.89x
3.72%FCF Yield3.41%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.559
252-Day Correlation
0.426
126-Day Correlation

Moderately correlated — some diversification benefit from holding both.

Fundamentals

MetricMRKA
Market Cap$293.2B$38.2B
P/E Ratio33.4x27.3x
Forward P/E12.4x20.5x
P/B6.39x5.37x
Dividend Yield2.86%0.75%
Beta0.201.22

Quantitative Metrics

MetricMRKA
DCF Fair Value$96.93$50.34
DCF Upside-19.3%-57.1%
Piotroski F4/95/9
Altman Z4.044.57
Beneish M-2.27-2.46
FCF Yield3.72%3.41%
Net Debt/EBITDA1.1x0.7x
ROIC16.3%11.8%
WACC7.4%12.1%
ROIC – WACC8.9pp-0.3pp
Gross Margin74.8%52.4%
Net Margin28.1%18.8%
Rev Growth YoY1.3%6.7%
Sharpe (1Y)1.430.32
Max Drawdown 3Y
FCF Payout Ratio66%24%

MRK Price

Loading chart...

A Price

Loading chart...

ETF Exposure

MRK found in:

XLV5.37%
IYH4.97%
VHT4.39%
SCHD4.24%
XPH1.82%
MOAT1.52%
DIA1.42%
MGV1.34%
QUS1.24%
VIG1.22%
DVY1.22%
VYM1.13%
VTV1.05%
SCHV1.04%
DGRW1.03%
SPYV1.00%
IWD0.98%
VONV0.83%
VFVA0.72%
ESGV0.60%
SCHX0.49%
SCHB0.46%
SPY0.45%
IVV0.45%
VOO0.44%
VFMO0.44%
SPTM0.42%
VONE0.41%
ITOT0.39%
VTI0.39%
SPLG0.37%
URTH0.36%
ACWI0.29%
VT0.24%
RSP0.22%
ONEO0.12%
VGK0.11%
SPDW0.06%
VSGX0.06%
CWI0.06%
VEA0.05%
VXUS0.04%
VEU0.04%

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

MRK vs A: Head-to-Head Analysis

Merck & Co., Inc. (MRK) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, A leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, MRK generates a return on invested capital (ROIC) of 16.3% compared to A's 11.8%. This suggests MRK is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between MRK and A is 0.559, indicating moderate co-movement, with some diversification value from holding both in a portfolio context.

MRK appears in 43 ETFs tracked by SecuritiesDB, while A appears in 29 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, MRK or A?

Our quantitative analysis compares MRK and A across nine fundamental dimensions. A wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are MRK and A correlated?

The 252-day correlation between MRK and A is 0.559. They show moderate correlation — partially diversifying.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.